Skip to main content

Advertisement

Log in

Can signal peptide-CUB-EGF domain-containing protein 1 (SCUBE-1) be used as an indicator of endothelial dysfunction in acromegaly patients?

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

Acromegaly is closely related to increased oxidative stress and endothelial dysfunction (ED). This study aimed to evaluate, for the first time in the literature, signal peptide-CUB-EGF domain-containing protein 1 (SCUBE-1) and endothelial nitric oxide synthase e(NOS) levels in the setting of acromegaly.

Method

A total of 56 acromegaly patients and a control group composed of 30 healthy volunteers were included in this study. In the postoperative follow-up, patients were grouped as active or in-remission according to their GH and IGF-1 levels in oral glucose stimulation test (OGST). After detailed physical examination of acromegaly patients and the control subjects, 8-hour fasting blood samples were collected to evaluate biochemical parameters including lipid profile, anterior pituitary hormones, and SCUBE-1 and e(NOS) levels.

Results

Inactive and active acromegaly was noted in 78.6% and 21.4% of patients, respectively. The median (min-max) SCUBE-1 levels were significantly higher in the inactive acromegaly and active acromegaly groups than in the control group (1.6(0.4–2.4) and 1.8(1.1–2.5) vs. 0.4(0.2–1.0) ng/mL, respectively, p < 0.001 for each). The median (min-max) e(NOS) levels were significantly higher in the inactive acromegaly and active acromegaly groups than in the control group (132.7 (26.8–602.9) and 137.3 (69.7–488.7) vs. 83.9 (16.4–218.7) pg/mL, p = 0.018 and p = 0.048, respectively). We have also detected positive correlations of e(NOS) with leukocyte (r = 0.307, p = 0.021) and neutrophil counts (r = 0.309, p = 0.021).

Conclusion

Our study revealed for the first time in literature that SCUBE-1 levels, being a novel marker for ED, were significantly higher in acromegaly patients than in control subjects. When supported with clinical studies, SCUBE-1can be used as an early indicator of endothelial damage in acromegaly patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. A. Fernandez, N. Karavitaki, J.A. Wass, Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin. Endocrinol. (Oxf) 72(3), 377–382 (2010). https://doi.org/10.1111/j.1365-2265.2009.03667.x

    Article  PubMed  Google Scholar 

  2. S. Bekkering, R.J.W. Arts, B. Novakovic, I. Kourtzelis, C.D.C.C. van der Heijden, Y. Li, C.D. Popa, R. Ter Horst, J. van Tuijl, R.T. Netea-Maier, F.L. van de Veerdonk, T. Chavakis, L.A.B. Joosten, J.W.M. van der Meer, H. Stunnenberg, N.P. Riksen, M.G. Netea, Metabolic Induction of Trained Immunity through the Mevalonate Pathway. Cell 172(1-2), 135–146.e9 (2018). https://doi.org/10.1016/j.cell.2017.11.025

    Article  CAS  PubMed  Google Scholar 

  3. T.L.C. Wolters, M.G. Netea, A.R.M.M. Hermus, J.W.A. Smit, R.T. Netea-Maier, IGF1 potentiates the pro-inflammatory response in human peripheral blood mononuclear cells via MAPK. J. Mol. Endocrinol. 59(2), 129–139 (2017). https://doi.org/10.1530/JME-17-0062

    Article  CAS  PubMed  Google Scholar 

  4. L. Liu, D. Leitner, Simultaneous pursuit of innovation and efficiency in complex engineering projects—A study of the antecedents and impacts of ambidexterity in project teams. Proj. Manag. J. 43(6), 97–110 (2012). https://doi.org/10.1002/pmj.21301

    Article  Google Scholar 

  5. G. Bodart, K. Farhat, C. Charlet-Renard, R. Salvatori, V. Geenen, H. Martens, The Somatotrope Growth Hormone-Releasing Hormone/Growth Hormone/Insulin-Like Growth Factor-1 Axis in Immunoregulation and Immunosenescence. Front. Horm. Res. 48, 147–159 (2017). https://doi.org/10.1159/000452913

    Article  CAS  PubMed  Google Scholar 

  6. A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr. Rev. 25(1), 102–152 (2004). https://doi.org/10.1210/er.2002-0022

    Article  CAS  PubMed  Google Scholar 

  7. S. Tellatin, P. Maffei, E. Osto, F. Dassie, G. Famoso, R. Montisci, C. Martini, F. Fallo, M.P. Marra, R. Mioni, S. Iliceto, R. Vettor, F. Tona, Coronary microvascular dysfunction may be related to IGF-1 in acromegalic patients and can be restored by therapy. Atherosclerosis 269, 100–105 (2018). https://doi.org/10.1016/j.atherosclerosis.2017.12.019

    Article  CAS  PubMed  Google Scholar 

  8. M.P. Warren, J. Brooks-Gunn, R.P. Fox, C.C. Holderness, E.P. Hyle, W.G. Hamilton, Osteopenia in exercise-associated amenorrhea using ballet dancers as a model: a longitudinal study. J. Clin. Endocrinol. Metab. 87(7), 3162–3168 (2002). https://doi.org/10.1210/jcem.87.7.8637

    Article  CAS  PubMed  Google Scholar 

  9. A. Colao, S. Spiezia, G. Cerbone, R. Pivonello, P. Marzullo, D. Ferone, C. Di Somma, A.P. Assanti, G. Lombardi, Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly. Clin. Endocrinol. (Oxf) 54(4), 515–524 (2001). https://doi.org/10.1046/j.1365-2265.2001.01256.x

    Article  CAS  PubMed  Google Scholar 

  10. I. Kartal, H. Oflaz, B. Pamukçu, M. Meriç, F. Aral, N. Ozbey, F. Alagöl, Investigation of early atherosclerotic changes in acromegalic patients. Int. J. Clin. Pract 64(1), 39–44 (2010). https://doi.org/10.1111/j.1742-1241.2008.01750.x

    Article  CAS  PubMed  Google Scholar 

  11. B.A. Bengtsson, S. Edén, I. Ernest, A. Odén, B. Sjögren, Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med. Scand. 223(4), 327–335 (1988). https://doi.org/10.1111/j.0954-6820.1988.tb15881.x

    Article  CAS  PubMed  Google Scholar 

  12. W. Che, N. Lerner-Marmarosh, Q. Huang, M. Osawa, S. Ohta, M. Yoshizumi, M. Glassman, J.D. Lee, C. Yan, B.C. Berk, J. Abe, Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ. Res. 90(11), 1222–1230 (2002). https://doi.org/10.1161/01.res.0000021127.83364.7d

    Article  CAS  PubMed  Google Scholar 

  13. L. Maione, T. Brue, A. Beckers, B. Delemer, P. Petrossians, F. Borson-Chazot, O. Chabre, P. François, J. Bertherat, C. Cortet-Rudelli, P. Chanson; French Acromegaly Registry Group, Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. Eur. J. Endocrinol. 176(5), 645–655 (2017). https://doi.org/10.1530/EJE-16-1064

    Article  CAS  PubMed  Google Scholar 

  14. R. Pivonello, R.S. Auriemma, L.F. Grasso, C. Pivonello, C. Simeoli, R. Patalano, M. Galdiero, A. Colao, Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20(1), 46–62 (2017). https://doi.org/10.1007/s11102-017-0797-7

    Article  PubMed  Google Scholar 

  15. M. Yang, M. Guo, Y. Hu, Y. Jiang, Scube regulates synovial angiogenesis-related signaling. Med. Hypotheses 81(5), 948–953 (2013). https://doi.org/10.1016/j.mehy.2013.09.001

    Article  PubMed  Google Scholar 

  16. R.B. Yang, C.K. Ng, S.M. Wasserman, S.D. Colman, S. Shenoy, F. Mehraban, L.G. Komuves, J.E. Tomlinson, J.N. Topper, Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. J. Biol. Chem. 277(48), 46364–46373 (2002). https://doi.org/10.1074/jbc.M207410200

    Article  CAS  PubMed  Google Scholar 

  17. L. Bronze, SCUBE 1: A novel biomarker related to platelet activation and atherothrombosis. SCUBE1 – Um novo biomarcador associado a ativação plaquetária e aterotrombose. Rev. Port. Cardiol. (Engl Ed). 37(5), 383–385 (2018). https://doi.org/10.1016/j.repc.2018.04.004

    Article  PubMed  Google Scholar 

  18. S. Turkmen, U. Eryigit, Y. Karaca, A. Mentese, U.A. Sumer, E. Yulug, N. Aksut, S. Gazioglu, A. Gunduz, Diagnostic value of plasma signal peptide-Cub-Egf domain-containing protein-1 (SCUBE-1) in an experimental model of acute ischemic stroke. Am. J. Emerg. Med. 33(2), 262–265 (2015). https://doi.org/10.1016/j.ajem.2014.11.051

    Article  PubMed  Google Scholar 

  19. G.A. Laughlin, E. Barrett-Connor, M.H. Criqui, D. Kritz-Silverstein, The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 89(1), 114–120 (2004). https://doi.org/10.1210/jc.2003-030967

    Article  CAS  PubMed  Google Scholar 

  20. M. Andreassen, I. Raymond, C. Kistorp, P. Hildebrandt, J. Faber, L.Ø. Kristensen, IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. Eur. J. Endocrinol. 160(1), 25–31 (2009). https://doi.org/10.1530/EJE-08-0452

    Article  CAS  PubMed  Google Scholar 

  21. S. Kul, O.T. Caklili, Y. Tutuncu, F.B. Ozcan, F. Aksu, O.F. Baycan, A. Atici, U.Z. Bilgili, M. Takir, M. Caliskan, Endothelial dysfunction in patients with acromegaly and It’s association with Endocan. Growth Horm. IGF Res. 56, 101362 (2021). https://doi.org/10.1016/j.ghir.2020.101362

    Article  CAS  PubMed  Google Scholar 

  22. D.F. Dai, P. Thajeb, C.F. Tu, F.T. Chiang, C.H. Chen, R.B. Yang, J.J. Chen, Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke. J. Am. Coll. Cardiol. 51(22), 2173–2180 (2008). https://doi.org/10.1016/j.jacc.2008.01.060

    Article  CAS  PubMed  Google Scholar 

  23. H. Uyanikoglu, N.G. Hilali, M. Yardimciel, I. Koyuncu, A new biomarker for the early diagnosis of ovarian torsion: SCUBE-1. Clin. Exp. Reprod. Med. 45(2), 94–99 (2018). https://doi.org/10.5653/cerm.2018.45.2.94

    Article  PubMed  PubMed Central  Google Scholar 

  24. A.A. Capkin, S. Demir, A. Mentese, Ç. Bulut, A. Ayar, Can signal peptide-CUB-EGF domain-containing protein (SCUBE) levels be a marker of angiogenesis in patients with psoriasis? Arch. Dermatol. Res. 309(3), 203–207 (2017). https://doi.org/10.1007/s00403-017-1722-7

    Article  CAS  PubMed  Google Scholar 

  25. T.L.C. Wolters, M.G. Netea, N.P. Riksen, A.R.M.M. Hermus, R.T. Netea-Maier, Acromegaly, inflammation and cardiovascular disease: a review. Rev. Endocr. Metab. Disord. 21(4), 547–568 (2020). https://doi.org/10.1007/s11154-020-09560-x

    Article  PubMed  PubMed Central  Google Scholar 

  26. M.F. Walsh, M. Barazi, G. Pete, R. Muniyappa, J.C. Dunbar, J.R. Sowers, Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology 137(5), 1798–1803 (1996). https://doi.org/10.1210/endo.137.5.8612517

    Article  CAS  PubMed  Google Scholar 

  27. H. Nishizawa, A.E. Handayaningsih, G. Iguchi, Y. Cho, M. Takahashi, M. Yamamoto, K. Suda, K. Kasahara, F. Hakuno, K. Yamanouchi, M. Nishihara, S. Seino, S. Takahashi, Y. Takahashi, Enhanced oxidative stress in GH-transgenic rat and acromegaly in humans. Growth Horm. IGF Res. 22(2), 64–68 (2012). https://doi.org/10.1016/j.ghir.2012.02.001

    Article  CAS  PubMed  Google Scholar 

  28. H. Ozisik, B.S. Yurekli, A. Suner, O. Copur, E.Y. Sozmen, S.S. Ozbek, A.K. Karabulut, I.Y. Simsir, M. Erdogan, S. Cetinkalp, F. Saygili, High chitotriosidase and AGE levels in acromegaly: a case-control study. Hormones (Athens) 22(1), 61–69 (2023). https://doi.org/10.1007/s42000-022-00409-3

    Article  PubMed  Google Scholar 

  29. L. Boero, L. Cuniberti, N. Magnani, M. Manavela, V. Yapur, M. Bustos, L. Gómez Rosso, T. Meroño, L. Marziali, L. Viale, P. Evelson, G. Negri, F. Brites, Increased oxidized low density lipoprotein associated with high ceruloplasmin activity in patients with active acromegaly. Clin. Endocrinol. (Oxf) 72(5), 654–660 (2010). https://doi.org/10.1111/j.1365-2265.2009.03685.x

    Article  CAS  PubMed  Google Scholar 

  30. S. Yarman, T.A. Ozden, C. Gökkuşu, The evaluation of lipid peroxidation and acute effect of octreotide on lipid peroxidation in patients with active acromegaly. Clin. Chim. Acta. 336(1-2), 45–48 (2003). https://doi.org/10.1016/s0009-8981(03)00328-0

    Article  CAS  PubMed  Google Scholar 

  31. C. Ozkan, A.E. Altinova, E.T. Cerit, C. Yayla, A. Sahinarslan, D. Sahin, A.S. Dincel, F.B. Toruner, M. Akturk, M. Arslan, Markers of early atherosclerosis, oxidative stress and inflammation in patients with acromegaly. Pituitary 18(5), 621–629 (2015). https://doi.org/10.1007/s11102-014-0621-6

    Article  CAS  PubMed  Google Scholar 

  32. M. Ilhan, S. Turgut, S. Turan, S. Demirci Cekic, H.A. Ergen, G. Korkmaz Dursun, B. Mezani, O. Karaman, I. Yaylim, M.R. Apak, E. Tasan, The assessment of total antioxidant capacity and superoxide dismutase levels, and the possible role of manganese superoxide dismutase polymorphism in acromegaly. Endocr. J. 65(1), 91–99 (2018). https://doi.org/10.1507/endocrj.EJ17-0300

    Article  PubMed  Google Scholar 

  33. T.L.C. Wolters, C.D.C.C. van der Heijden, N. van Leeuwen, B.T.P. Hijmans-Kersten, M.G. Netea, J.W. Smit, D.H.J. Thijssen, A. Hermus, N.P. Riksen, R. Netea-Maier, Persistent inflammation and endothelial dysfunction in patients with treated acromegaly. Endocr. Connect 8(12), 1553–1567 (2019). https://doi.org/10.1530/EC-19-0430

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. D.S. Celermajer, K.E. Sorensen, C. Bull, J. Robinson, J.E. Deanfield, Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J. Am. Coll. Cardiol. 24(6), 1468–1474 (1994). https://doi.org/10.1016/0735-1097(94)90141-4

    Article  CAS  PubMed  Google Scholar 

  35. P. Maffei, F. Dassie, A. Wennberg, M. Parolin, R. Vettor, The endothelium in acromegaly. Front. Endocrinol. (Lausanne) 10, 437 (2019). https://doi.org/10.3389/fendo.2019.00437

    Article  PubMed  Google Scholar 

  36. G. Ozkan, S. Ulusoy, A. Menteşe, S.C. Karahan, M. Cansız, New marker of platelet activation, SCUBE1, is elevated in hypertensive patients. Am. J. Hypertens. 26(6), 748–753 (2013). https://doi.org/10.1093/ajh/hpt007

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

CRediT authorship contribution statement. Conceptualization: D.T., I.N., S.C.K. Methodology: D.T., I.N., H.C. Data curation: D.T., I.N., H.C., M.K., O.U., C.B., Y.E.G. Formal analysis: S.S.A., S.C.K., S.O.Y., M.C.B. Investigation: S.C.K., M.K., O.U. Project administration: S.S.A. Writing-original draft preparation: D.T., S.O.Y., M.C.B. Writing- review & editing: D.T., M.K., H.C., M.C.B. Supervision: S.S.A., O.U., M.C.B.

Corresponding author

Correspondence to Damla Tufekci.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Consent to participate

Written informed consent was obtained from each subject following a detailed explanation of the objectives and protocol of the study.

Ethics approval

The study protocol was approved by the Karadeniz Teknik University Ethics Committee (Date of Approval : 30/06/2021, Protocol no:2021/595-24237859).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tufekci, D., Nuhoglu, I., Ayan, S.S. et al. Can signal peptide-CUB-EGF domain-containing protein 1 (SCUBE-1) be used as an indicator of endothelial dysfunction in acromegaly patients?. Endocrine 82, 152–160 (2023). https://doi.org/10.1007/s12020-023-03444-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-023-03444-1

Keywords

Navigation